Biotech Big Losers: Achillion Pharmaceuticals (NASDAQ:ACHN), Can-Fite BioPharma (NYSEMKT:CANF), Calithera Biosciences (NASDAQ:CALA), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), Codexis (NASDAQ:CDXS)

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced the pricing of an underwritten public offering of 12 million shares of its common stock at a price to the public of $10.25 per share. All shares in the offering will be sold by Achillion. On Wednesday shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) closed at $10.87. Company’s EPS growth for next 5 years is recorded as 17.58%.

On 4 February, Can-Fite BioPharma Ltd. (NYSE MKT: CANF) announced that all patients enrolled in its Phase II/III psoriasis trial for the Company’s drug candidate CF101 have completed the study’s 32 week treatment protocol. Can-Fite BioPharma Ltd. (NYSEMKT:CANF) in last trading activity decreased -5.28% to close at $3.59. Company weekly performance is -1.10% while its quarterly performance stands at 30.55%. Can-Fite BioPharma Ltd. (NYSEMKT:CANF) is -43.38% away from its 52 week high.

On 30 January, Calithera Biosciences, Inc. (NASDAQ:CALA), announced the appointment of Dr. Keith Orford, M.D. Ph.D., as Vice President of Clinical Development. On last trading day Calithera Biosciences, Inc. (NASDAQ:CALA) decreased -8.58% to close at $16.40. Its volatility for the week is 9.78% while volatility for the month is 10.12%. Calithera Biosciences, Inc. (NASDAQ:CALA) monthly performance is -28.26%.

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) participated in the 17th Annual BIO CEO & Investor Conference, on February 9-10, 2015 in New York City. Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) has 11.50% insider ownership while its institutional ownership stands at 17.80%. In last trading activity company’s stock closed at $4.51.

Codexis, Inc. (NASDAQ:CDXS) President and CEO John Nicols and Senior Vice President and CFO Gordon Sangster presented at the 17th Annual BIO CEO & Investor Conference on Monday, February 9, 2015. On last trading day Codexis, Inc. (NASDAQ:CDXS) decreased -5.57% to close at $3.39. Its volatility for the week is 5.91% while volatility for the month is 6.99%. CDXS’s sales growth for past 5 years was -8.80% and its EPS growth for past 5 years was 43.60%. Codexis, Inc. (NASDAQ:CDXS) monthly performance is 6.27%.

Leave a Reply

Your email address will not be published. Required fields are marked *

*